Tatsuji Mino1, Takeshi Okatani1, Ryota Imanaka1, Kohei Kyo1, Mitsuhiro Itagaki1, Shinya Katsutani1, Yuta Katayama1, Koji Iwato2, Hideki Asaoku1 (1.Dept. Hematology, Hiroshima Red Cross Hospital, Hiroshima, Japan, 2.Dept. transfusion, Hiroshima Red Cross Hospital, Hiroshima, Japan)
Session information
Oral Session
Oral Session 1-12A Transplant outcomes (1)
Fri. Oct 12, 2018 9:00 AM - 10:00 AM No.12 (Osaka International Convention Center, 10F 1006-7)
Chair: Takehiko Mori (Division of Hematology, Depaertment of Medicine, Japan)
Hiroaki Araie, Tomoe Ichiki, Yuka Kawaguchi, Motohito Okabe, Yoonha Lee, Marie Ohbiki, Masahide Osaki, Miyo Goto, Takahiko Sato, Tatsunori Goto, Takanobu Morishita, Yukiyasu Ozawa, Koichi Miyamura (The department of hematology, Japanese Red Cross Nagoya First Hospital)
Hirofumi Yokota, Yuki Takeuchi, Shihomi Taniyama, Hitomi Sawa, Kanae Imai, Yuichiro Inagaki, Tomonori Kato, Masashi Sawa (Anjo Kosei Hospital)
Hiroatsu Ago, Toshio Wakayama (Department of Hematology and Oncology,Shimane Prefectural Central Hospital,Japan)
Miki Iwamoto, Yusuke Meguri, Shuntaro Ikegawa, Hiroyuki Sugiura, Yasuhisa Sando, Makoto Nakamura, Takeru Asano, Yoshinobu Maeda, Ken-Ichi Matsuoka (Department of Lematology and Oncology, Okayama Univ., Okayama, Japan)
Junichi Sugita1, Shuichi Ota2, Tomohiko Kamimura3, Eijiro Omoto4, Takashi Kuroha5, Keitaro Matsuo6, Koichi Akashi7, Shuichi Taniguchi8, Mine Harada9, Takanori Teshima1 (1.Hematology, Faculty of Medicine, Hokkaido University, Sapporo, Japan, 2.Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan, 3.Hematology, Harasanshin Hospital, Fukuoka, Japan, 4.Hematology, Yamagata Prefectural Central Hospital, Yamagata, Japan, 5.Hematology, Nagaoka Red Cross Hospital, Nagaoka, Japan, 6.Molecular Medicine, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan, 7.Hematology/Oncology, Kyushu University Hospital, Fukuoka, Japan, 8.Hematology, Toranomon Hospital, Tokyo, Japan, 9.Karatsu Higashimatsuura Medical Center, Karatsu, Japan)